UMass Memorial Medical Center, Inc., commonly referred to as UMass Memorial, is a leading provider in the field of anatomic pathology outreach laboratory services, headquartered in the United States. Established in 1986, the centre has made significant strides in delivering high-quality diagnostic services across New England and beyond. Specialising in a comprehensive range of pathology services, UMass Memorial stands out for its commitment to accuracy and innovation in diagnostics. The laboratory offers unique solutions tailored to the needs of healthcare providers, ensuring timely and precise results that enhance patient care. With a strong market position, UMass Memorial has garnered recognition for its exceptional service and expertise in anatomic pathology, making it a trusted partner for hospitals and clinics seeking reliable laboratory support.
How does UMass Memorial Medical Center, Inc., Anatomic Pathology Outreach Laboratory Business's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
UMass Memorial Medical Center, Inc., Anatomic Pathology Outreach Laboratory Business's score of 11 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
UMass Memorial Medical Center, Inc., Anatomic Pathology Outreach Laboratory Business currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The organisation is part of a merged entity and inherits its climate-related data from Quest Diagnostics Incorporated, which operates at a cascade level of 1. While there are no documented reduction targets or climate pledges specific to UMass Memorial Medical Center, the overarching corporate family context suggests a commitment to sustainability through the initiatives of Quest Diagnostics. However, specific details regarding emissions reductions or climate commitments are not available. As the healthcare sector increasingly focuses on reducing its carbon footprint, UMass Memorial Medical Center's lack of reported emissions data highlights an opportunity for future transparency and accountability in climate action. The organisation's alignment with industry standards and potential future commitments will be crucial in addressing climate change effectively.
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Scope 1 | 83,929,000 | 00,000,000 | - | 000,000,000 | 000,000,000 |
| Scope 2 | 145,724,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 3 | 41,299,000 | 00,000,000 | 00,000,000 | - | 000,000,000 |
UMass Memorial Medical Center, Inc., Anatomic Pathology Outreach Laboratory Business's Scope 3 emissions, which increased significantly last year and increased significantly since 2015, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 62% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
UMass Memorial Medical Center, Inc., Anatomic Pathology Outreach Laboratory Business has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.